Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company’s Growth
Provided By GlobeNewswire
Last update: Feb 18, 2025
-- Mr. Iwicki Brings Track Record of Operational Excellence and Significant Expertise in PAH and Cardiovascular Diseases --
-- Amit Munshi Appointed Chair of the Board of Directors --
Read more at globenewswire.com
